Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ChromeMate Reduces Vascular Inflammation - Nutraceuticals World

What are you searching for?

Sign in
Research

ChromeMate Reduces Vascular Inflammation

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

A new research study funded by the National Institutes of Health (NIH) showed that ChromeMate, InterHealth Nutraceutical’s patented niacin-bound chromium complex, significantly reduced vascular inflammation, while chromium picolinate did not.

The 8-week study looked at blood markers for vascular inflammation, including TNF-a, MCP-1, retinol binding protein-4 (RBP-4), cholesterol and triglycerides in obese Zucker diabetic rats. The diets of test animals were supplemented with 400 mcg of chromium (III) from ChromeMate or chromium picolinate per kilogram of body weight.

When compared with animals in the control group, the ChromeMate group experienced significantly lower total cholesterol and triglycerides than the group supplemented with chromium picolinate. Levels of TNF-a MCP-1, RBP-4 were also lower in the ChromeMate group compared to the control group; the chromium picolinate group did not experience any reduction in those markers.

For further information: 800-783-4636.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics